Skip to content
Recall Observatory FDA recall evidence

Drug product

Rosuvastatin 10mg tablets, packaged in a) 30-count bottles (NDC 70518-0375-03 and 70518-0375-01) and b) 90-count bottles (NDC 70518-0375-00), Rx only, Repackaged by: RemedyRepack Inc., Indiana, PA 15701.

D-0501-2023

March 20, 2023

Class II

Product summary

Firm
RemedyRepack Inc.
Event
Event 91980
Status
Terminated
Classification
Class II
Quantity
a) 399 bottles, b)445 bottles
Official record key
drug-enforcement:D-0501-2023

Official wording

Reason: cGMP Deviations

Code information: Lot#: a) NDC 70518-0375-03: J0674788-011123, Exp. Date 01/31/2024; J0664118-112922 J0664118-112922, Exp. Date 12/31/2023; J0653727-101722, Exp. Date 10/31/2023. NDC 70518-0375-01: B2057931-011223, Exp. Date 07/31/2025 b) Lot #: B2075815-012523, Exp. Date 09/30/2025; B2011634-121322, Exp. Date 07/31/2025 B1970205-112022, Exp. Date 06/30/2024; B1862598-092022, Exp. Date 03/31/2024; B2077226-012523, B2070444-012023, Exp. Date 07/31/2025.

Distribution pattern: RemedyRepack distributed product to consignees nationwide within the United States

Derived failure modes

  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    cGMP Deviations